Marksans Pharma Limited

符号: MARKSANS.NS

NSE

162.35

INR

今天的市场价格

22.5480
市盈率
0.8053
PEG比率
73.57B
MRK市值
0.00%
DIV收益率

Marksans Pharma Limited (MARKSANS-NS) 财务报表

Q: 什么是 Marksans Pharma Limited (MARKSANS.NS) 总资产是多少？

Marksans Pharma Limited (MARKSANS.NS) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Marksans Pharma Limited (MARKSANS.NS). 的默认数据。公司收入显示 7206.416 M 的平均值，即 0.110 % 增长率。整个期间的平均毛利润为 3092.738 M，即 0.151 %. 平均毛利率为 0.365 %. 公司去年的净收入增长率为 0.443 %，等于 -0.591 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Marksans Pharma Limited 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 0.336. 在流动资产领域，MARKSANS.NS 的报告货币为16753.01. 这些资产中的很大一部分，即 7191.57 是现金和短期投资。与去年的数据相比，该部分的变化率为1.074%. 公司的债务概况显示，以报告货币计算的长期债务总额为 656.89. 这一数字表明，0.110% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 17451.62. 这方面的年同比变化率为 0.452%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为4187.62，存货估值为 4847.39，商誉估值为 384.89（如有. 无形资产总额（如果有）按 707.97 估值.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005
balance-sheet.row.cash-and-short-term-investments	27678.4	7191.6	3466.9	2093.8	931.2	328.5	397.2	251.6	353	1852.7	469.5	158.8	223.9	309.2	355	223.4	615.9	1586.9	1976.1	97.1
balance-sheet.row.short-term-investments	34038.7	3367.2	4.3	17.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	8696.08	4187.6	4115.6	2767.3	2439.6	1844	0	0	0	0	0	0	0	0	0	0	0	0	636.4	690.4
balance-sheet.row.inventory	10153.42	4847.4	4244.4	4043.2	2418.4	2932.5	2181.2	1900.9	1677.9	1301.1	1025.9	776.9	733.6	672.2	1045.2	1190.8	1394.3	1239.3	789.1	524.2
balance-sheet.row.other-current-assets	1029.74	526.4	185.1	118.2	112.6	209.4	1911.1	2685.4	2370.5	1934.6	1934.1	1503.5	1231.8	1151.5	1158.4	1192.3	897.4	745.8	19	21.6
balance-sheet.row.total-current-assets	47557.64	16753	12012	9022.5	5901.9	5314.4	4489.5	4837.9	4401.5	5088.3	3429.5	2439.3	2189.3	2132.9	2558.7	2606.5	2907.6	3572	3420.6	1333.2
balance-sheet.row.property-plant-equipment-net	8581.34	3868.9	3422.9	2540.2	2200.8	1980.8	1863.7	1648.6	1641.4	1023.7	724.8	741.3	738.7	2785.9	3917.2	3804.6	2703.3	1398.1	1248.7	1016.6
balance-sheet.row.goodwill	771.91	384.9	300.3	195.9	243.8	314.5	617.5	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	1395.4	708	585.7	474.4	582.6	401.9	312.6	0	0	0	0	0	914.9	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	2167.31	1092.9	885.9	670.2	826.4	716.4	930.1	1024.7	1055.2	635.3	731.7	819.9	914.9	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	-6433	-3332.4	-62	8.4	3060.2	0	0	-1024.7	-1055.2	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	6517.3	3375.9	38.6	8	6.3	12.5	0	2.7	19.1	0	0	0	0	-157.1	-122.1	-119.6	-108.6	-85	0	0
balance-sheet.row.other-non-current-assets	-13350.95	145.7	103.7	33.2	-3027.2	12.9	8.2	1033.4	1159.2	8.3	15	12	40.8	1775.8	102.1	4.8	10.8	19	0.1	0.1
balance-sheet.row.total-non-current-assets	-2518	5150.9	4389	3260	3066.5	2722.7	2801.9	2684.7	2819.7	1667.2	1471.5	1573.2	1694.4	4404.6	3897.2	3689.9	2605.5	1332.1	1248.7	1016.7
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	45039.64	21903.9	16401	12282.5	8968.4	8037.1	7291.5	7522.6	7221.2	6755.5	4901	4012.4	3883.6	6537.5	6455.8	6296.4	5513.1	4904.2	4669.3	2349.9
balance-sheet.row.account-payables	4309.35	2306	2000.8	1686.6	1045	1060.7	674.8	1617.8	1189.8	1070.2	831.8	560.6	0	0	0	0	0	0	0	0
balance-sheet.row.short-term-debt	1073.1	572.6	693.4	247.8	188.9	1002.2	1179.6	1097.1	884.8	821.9	1055.4	1137.9	0	0	0	0	0	0	0	0
balance-sheet.row.tax-payables	667.33	252.8	173.3	300.2	118.6	49	90.4	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	1267.38	656.9	414.3	93.3	107.6	100	0	0	0	0	198.2	78.8	152	4767.5	4240.3	3965.4	3378.7	3187.2	3038.6	897.5
Deferred Revenue Non Current	0	0	0	121.1	114.7	-100	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	321.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	376.6	112.4	543	639.3	480.7	132.6	5.8	6	0	398.8	965.8	1087.3	5225.6	620.5	595.5	821.2	713.2	453.2	434.3	429.3
balance-sheet.row.total-non-current-liabilities	1681.51	843.3	609.1	245	280.3	183.9	156.4	0	0	14.6	221.6	104.9	282.6	4767.5	4240.3	3965.4	3378.7	3187.2	3038.6	897.5
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	1572.51	813.6	694.9	153.6	107.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	8418.8	4253.2	4171.3	3229	2477.2	2510.1	2487.3	3014.3	2594.3	2876.9	3412.8	3077.8	5508.2	5387.9	4835.7	4786.6	4092	3640.3	3472.9	1326.8
balance-sheet.row.preferred-stock	13274.17	13274.2	0	0	10828.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	906.32	453.2	409.3	409.3	409.3	409.3	409.3	519.3	534.3	534.3	520.3	520.3	502.8	502.8	502.8	502.8	494.4	494.4	494.4	494.4
balance-sheet.row.retained-earnings	10913.4	10913.4	5093.1	3349.3	851.1	29.8	-690.7	-985.2	-920.1	-1525.6	-2539.8	-3154.7	0	0	0	0	0	0	424.2	195.3
balance-sheet.row.accumulated-other-comprehensive-income-loss	58687.73	4177.4	4788.4	3355	-1331.1	-1148.8	-1032.2	-889.6	-748.1	-617.1	-563.4	-512.7	-452.9	-615.4	-936.8	-786.4	-638.5	-386.1	-313.7	-235.7
balance-sheet.row.other-total-stockholders-equity	-10953.25	-11366.6	1731.9	1751.3	-4397.8	6134.6	6022.2	5801.3	5677.1	5406	4004.7	4011.9	-1730.6	1237.1	2044.9	1786.5	1562.5	1156	591.4	569.1
balance-sheet.row.total-stockholders-equity	72828.37	17451.6	12022.7	8864.9	6360.1	5424.8	4708.6	4445.8	4543.2	3797.6	1421.8	864.8	-1680.7	1124.4	1610.9	1502.9	1418.5	1264.2	1196.3	1023.1
balance-sheet.row.total-liabilities-and-stockholders-equity	81660.48	21903.9	16401	12282.5	8968.4	8037.1	7291.5	7522.6	7221.2	6755.5	4901	4012.4	3883.6	6537.5	6455.8	6296.4	5513.1	4904.2	4669.3	2349.9
balance-sheet.row.minority-interest	413.31	199.1	207	188.6	131.1	102.2	95.5	62.5	83.6	81	66.4	69.9	56.2	25.1	9.1	6.9	2.7	-0.4	0	0
balance-sheet.row.total-equity	73241.68	17650.7	12229.7	9053.5	6491.2	5527	4804.1	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	81660.48	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	27605.7	34.8	26.1	25.6	3060.2	0	0	-1024.7	-1055.2	0	0	0	0	0	100	0	0	0	0.1	0.1
balance-sheet.row.total-debt	2340.48	1229.5	1107.8	341	296.5	1002.2	1179.6	1097.1	884.8	821.9	1253.5	1216.6	152	4767.5	4240.3	3965.4	3378.7	3187.2	3038.6	897.5
balance-sheet.row.net-debt	8700.78	-2594.9	-2354.8	-1752.8	-634.7	673.6	782.5	845.5	531.8	-1030.8	784.1	1057.8	-71.9	4458.3	3885.3	3741.9	2762.9	1600.3	1062.6	800.5

现金流量表

在 Marksans Pharma Limited 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 2.472 的转变。该公司最近通过发行 2747.09 扩大了股本，与上一年相比出现了10.713 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-2592120000.000. 与上一年相比， 5.218 发生了变化. 在同一时期，公司记录了 518.53, -2055.81 和 -2295.43，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-101.71 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 2080，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007
cash-flows.row.net-income	3181.21	3376.5	2475.1	3021.6	1571.7	1043.1	498	155.3	1068.5	1094	719.1	458.8	-1788.4	-2232.4	-100.4	-83.6	154.2	67.9
cash-flows.row.depreciation-and-amortization	671.58	518.5	447.8	361.5	266.6	228	268.4	300.9	281.3	161.3	156.9	156.5	0.1	199.8	154.7	153.5	92.9	73.3
cash-flows.row.deferred-income-tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	0	-1114.7	-1107	-1500.3	357.3	-817.9	-274	-241	-841.6	208.5	-260.1	-261.1	-80.6	405	-46.3	45.2	-46.6	-492.3
cash-flows.row.account-receivables	0	-275.2	-1039.3	-367.4	-667.5	3.1	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	0	-448.5	-178.5	-1624.8	514	-751.2	-280.4	-223	-376.8	-275.2	-249	-43.3	-61.4	373	145.6	203.5	-155	-450.3
cash-flows.row.account-payables	0	224.2	184.9	417.8	665.7	90.4	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-615.2	-74.1	74.1	-154.9	-160.2	6.4	-18	-464.8	483.7	-11.1	-217.7	-19.2	31.9	-191.9	-158.3	108.4	-42
cash-flows.row.other-non-cash-items	-3181.21	-406.3	-823.3	-95.5	-96.2	-179.2	96.8	-126.8	-200.1	81.3	32.5	31.3	1245.9	896.2	161.2	84.9	31.1	-9.4
cash-flows.row.net-cash-provided-by-operating-activities	1343.16	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	0	-536.3	-463.3	-464.2	-596.3	-131.5	-389.4	-277.5	-1318.7	-364.7	0	0	-52.8	129.4	-268.7	-1256.8	-1398.3	-222.7
cash-flows.row.acquisitions-net	0	-266.1	0.3	5.2	2.8	0	0	0	0	0	-52.1	-64.3	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	0	-1897.7	-1.5	0	0	0	0	0	0	0	0	0	0	100	-100	0	0	0.1
cash-flows.row.sales-maturities-of-investments	0	2163.8	-0.3	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	0	-2055.8	47.9	10.1	-1.9	-4.3	1.6	69.1	88.6	32.8	7.2	10	20.3	16.7	15.4	76.4	57.4	95.5
cash-flows.row.net-cash-used-for-investing-activites	0	-2592.1	-416.9	-449	-595.3	-134.8	-387.8	-208.4	-1230.1	-331.9	-44.9	-54.3	-32.5	246.1	-353.3	-1180.5	-1340.9	-127.2
cash-flows.row.debt-repayment	0	-2295.4	-225.5	-1	-703	-66.8	0	0	-335	-998.7	-84.6	-2351.2	0	0	-243.6	-13.8	-181	-52.5
cash-flows.row.common-stock-issued	0	2747.1	911.5	0	703	0	0	0	0	1312.4	0	44.8	11.6	0	-2.2	171.2	0	0
cash-flows.row.common-stock-repurchased	0	-451.7	-225.5	0	-50	0	-10	-15	0	-10	0	-114.5	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	-101.7	-105.8	-40.9	-295	-44.4	-24.6	-145.3	-179.6	-69.7	-104.2	-46.8	-2.7	0	0	-5.5	0	0
cash-flows.row.other-financing-activites	0	2080	440.4	-110.9	-556.4	-96.6	-19.6	178.9	-62.9	-64.1	-104	2071.3	561.3	439.5	561.4	436	319.4	151.1
cash-flows.row.net-cash-used-provided-by-financing-activities	0	1978.3	795.1	-152.9	-901.5	-207.8	-54.3	18.6	-577.5	169.9	-292.8	-396.4	570.2	439.6	315.6	587.8	138.4	98.6
cash-flows.row.effect-of-forex-changes-on-cash	0	0	-1428.6	-1	6.1	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	1343.16	1760.3	1370.8	1185.6	602.7	-68.6	147.1	-101.4	-1499.6	1383.2	310.7	-65.1	-85.3	-45.8	131.6	-392.4	-971	-389.2
cash-flows.row.cash-at-end-of-period	21580.94	3824.4	3492.7	2122.9	931.2	328.5	398.8	251.6	353	1852.7	469.5	158.8	223.9	309.2	355	223.4	615.9	1586.9
cash-flows.row.cash-at-beginning-of-period	20237.78	2064.1	2121.8	937.3	328.5	397.2	251.6	353	1852.7	469.5	158.8	223.9	309.2	355	223.4	615.9	1586.9	1976.1
cash-flows.row.operating-cash-flow	1343.16	2374.1	992.6	1787.4	2099.4	274	589.2	88.4	308	1545.1	648.4	385.6	-623	-731.5	169.2	200.2	231.5	-360.6
cash-flows.row.capital-expenditure	0	-536.3	-463.3	-464.2	-596.3	-131.5	-389.4	-277.5	-1318.7	-364.7	0	0	-52.8	129.4	-268.7	-1256.8	-1398.3	-222.7
cash-flows.row.free-cash-flow	1343.16	1837.8	529.3	1323.2	1503.2	142.5	199.9	-189.1	-1010.7	1180.5	648.4	385.6	-675.8	-602.1	-99.5	-1056.6	-1166.7	-583.3

利润表行

Marksans Pharma Limited 的收入与上期相比变化了 0.251%。据报告, MARKSANS.NS 的毛利润为 9307.81。该公司的营业费用为 6433.13，与上年相比变化了 24.825%. 折旧和摊销费用为 518.53，与上一会计期间相比变化了 0.158%. 营业费用报告为 6433.13，显示24.825% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长0.344%. 营业收入为 2877.32，与上年相比变化了0.344%. 净利润的变化率为 0.443%。去年的净收入为2663.08.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005
income-statement-row.row.total-revenue	21033.72	18521.4	14801.2	13683.7	11293.3	9873.3	9126.9	7671.6	8933.3	7966.9	6300	4384.2	3555.5	3053.2	3593.7	3601.3	2639.4	2419.9	2974.1	2529
income-statement-row.row.cost-of-revenue	10121.39	9213.6	7480.2	6186	5683.4	5174.9	5481.8	4720.2	5096.9	4454.4	3679.3	2528.6	2129.3	2375.3	2941.7	2866.6	2001.8	1967.4	2291.5	1886.9
income-statement-row.row.gross-profit	10912.33	9307.8	7321.1	7497.8	5610	4698.4	3645.1	2951.4	3836.3	3512.5	2620.7	1855.6	1426.2	677.9	651.9	734.7	637.6	452.5	682.5	642
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	283.89	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	449.01	593.1	95.6	38.7	1.5	0.9	2	2498.4	2479.7	1826	1599.5	1309.2	2640.5	184.2	139.1	78.9	35.7	-23.5	33.4	53.1
income-statement-row.row.operating-expenses	6999.05	6433.1	5153.7	4310.6	3953.1	3605	3129.1	2927.2	2793.4	1826	1599.5	1309.2	2640.5	710.4	546.6	521.3	351.4	272	273.9	267.3
income-statement-row.row.cost-and-expenses	17120.44	15646.7	12633.9	10496.6	9636.4	8780	8610.9	7647.4	7890.3	6280.3	5278.8	3837.9	4769.8	3085.7	3488.3	3387.9	2353.3	2239.4	2565.4	2154.3
income-statement-row.row.interest-income	158.31	59.4	59.7	11.6	1	0.9	1.1	2.2	24.8	32.8	7.2	10	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	88.03	91.3	53.9	34.7	49.7	59.2	64.9	39.6	62.9	87	0	0	535.8	1102.1	192.3	213.6	118.6	115	50.4	59.3
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	12.93	499.2	334.1	-70.6	-130.7	-50.3	-18	131	25.6	-127.7	-157.1	-110.9	-535.8	-2121.9	-197.6	-283.4	-81	-87.2	-94.6	-124
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	449.01	593.1	95.6	38.7	1.5	0.9	2	2498.4	2479.7	1826	1599.5	1309.2	2640.5	184.2	139.1	78.9	35.7	-23.5	33.4	53.1
income-statement-row.row.total-operating-expenses	12.93	499.2	334.1	-70.6	-130.7	-50.3	-18	131	25.6	-127.7	-157.1	-110.9	-535.8	-2121.9	-197.6	-283.4	-81	-87.2	-94.6	-124
income-statement-row.row.interest-expense	88.03	91.3	53.9	34.7	49.7	59.2	64.9	39.6	62.9	87	0	0	535.8	1102.1	192.3	213.6	118.6	115	50.4	59.3
income-statement-row.row.depreciation-and-amortization	671.58	518.5	447.8	361.5	266.6	228	268.4	300.9	281.3	161.3	156.9	156.5	0.1	199.8	154.7	153.5	92.9	73.3	80.5	69.5
income-statement-row.row.ebitda-caps	5033.87	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	4261.33	2877.3	2141	3092.2	1702.4	1093.3	516	155.3	1068.5	1558.8	864.1	435.5	-1214.3	-32.5	105.4	213.4	286.1	180.5	314.1	250.7
income-statement-row.row.income-before-tax	4274.26	3376.5	2475.1	3021.6	1571.7	1043.1	498	155.3	1068.5	1558.8	864.1	435.5	-1750	-2154.4	-92.3	-70	205.1	93.3	314.1	250.7
income-statement-row.row.income-tax-expense	1074.63	723.3	607	636.3	364.2	238.7	140	35.1	241.1	439.2	127.9	-52.8	10.8	64.1	4	9.6	47.9	26.4	85.1	45.1
income-statement-row.row.net-income	3173.43	2663.1	1845.7	2385.4	1207.5	804.4	329.4	95.2	785.1	1094	719.1	458.8	-1788.4	-2232.4	-100.4	-83.6	157.2	66.9	228.9	205.6